Skip to main content

Androgen receptor phosphorylation at serine residue 578 predicts poor outcome in hormone-naïve prostate cancer patients

12 stars
Taylor
Bruce
Institute of Cancer Sciences, Wolfson Wohl Cancer Research Centre
University of Glasgow
Glasgow
Scotland
Show all authors
Patek
SC
Institute of Cancer Sciences, Wolfson Wohl Cancer Research Centre
University of Glasgow
Glasgow
Scotland
Underwood
MA
Department of Urology
Queen Elizabeth University Hospital
Glasgow
Scotland
Edwards
J
Institute of Cancer Sciences, Wolfson Wohl Cancer Research Centre
University of Glasgow
Glasgow
Scotland

Tabs

Speciality: 
Urology
Keywords: 
androgen receptor, Biomarker, phosphorylation, Prostate cancer, hormone-naive, protein kinase C, PKC